What is HC Wainwright’s Estimate for FibroGen Q1 Earnings?
FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Research analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of FibroGen in a report released on Tuesday, March 18th. HC Wainwright analyst M. Keller expects that the biopharmaceutical company will post earnings of $0.04 per share for the quarter. HC Wainwright has a “Buy” […]
